{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:02:21Z","timestamp":1704844941408},"reference-count":127,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":5113,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1046\/j.0022-202x.2001.00049.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T04:37:46Z","timestamp":1047443866000},"page":"212-218","source":"Crossref","is-referenced-by-count":7,"title":["Immune Reconstitution in HIV-1-Infected Individuals Treated with Potent Antiretroviral Therapy"],"prefix":"10.1016","volume":"6","author":[{"given":"Elizabeth","family":"Connick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0010","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1086\/314469","article-title":"Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy","volume":"178","author":"Aberg","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0015","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00002030-199810000-00006","article-title":"Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy","volume":"12","author":"Albrecht","year":"1998","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00002030-200005050-00001","article-title":"Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease","volume":"14","author":"Al-Harthi","year":"2000","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0030","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0140-6736(05)62137-X","article-title":"Remission of progressive multifocal leukoencephalopathy after antiretroviral therapy","volume":"349","author":"Baldeweg","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0035","first-page":"1526","article-title":"Regression of progressive multifocal leukoencephalopathy with highly active antiretroviral therapy","volume":"11","author":"Baqi","year":"1997","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0040","first-page":"68","article-title":"Early production of HIV-1 neutralising antibodies in patients following highly active antiretroviral treatment (HAART) during primary HIV infection","volume":"14","author":"Barassi","year":"2000","journal-title":"J Biol Regulators Homeostatic Agents"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/348163a0","article-title":"Interconversion of CD45R subsets of CD4T cells in vivo","volume":"348","author":"Bell","year":"1990","journal-title":"Nature"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0050","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/334706a0","article-title":"Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune human","volume":"334","author":"Berzofsky","year":"1988","journal-title":"Nature"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0055","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/00002030-199816000-00006","article-title":"Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities","volume":"12","author":"Bisset","year":"1998","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-119-3-199308010-00001","article-title":"Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients","volume":"119","author":"Blatt","year":"1993","journal-title":"Ann Int Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm0297-205","article-title":"Antiviral pressure exerted by HIV-1-specific T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus","volume":"3","author":"Borrow","year":"1997","journal-title":"Nature Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0070","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-199714000-00010","article-title":"Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy","volume":"11","author":"Brodt","year":"1997","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0075","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI5863","article-title":"Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues","volume":"103","author":"Bucy","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0080","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(97)04161-5","article-title":"Randomised, placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group","volume":"351","author":"Cameron","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.283.3.381","article-title":"Antiretroviral therpay in adults. Updated recommendations of the international AIDS society-USA panel","volume":"283","author":"Carpenter","year":"2000","journal-title":"JAMA"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0090","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(05)62892-9","article-title":"Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor","volume":"349","author":"Carr","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0095","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(97)07529-6","article-title":"Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0100","first-page":"38","volume":"10","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"HIV\/AIDS Surveillance Report"},{"issue":"RR10","key":"10.1046\/j.0022-202x.2001.00049.x_bb0105","first-page":"1","article-title":"1999 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0110","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1378\/chest.114.3.933","article-title":"Paradoxical reactions in HIV and pulmonary TB","volume":"114","author":"Chien","year":"1998","journal-title":"Chest"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0115","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199809173391216","article-title":"Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy","volume":"339","author":"Cinque","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0120","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1172\/JCI114376","article-title":"Detection of three distinct patterns of T helper cell dysfunction in asymptomatic human immunodeficiency virus-seropositive patients: independence of CD4+ cell numbers and clinical staging","volume":"84","author":"Clerici","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0125","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM199604183341602","article-title":"Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine","volume":"334","author":"Collier","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/34929","article-title":"HIV-1 nef protein protects infected primary cells against killing by cytotoxic T lymphocytes","volume":"391","author":"Collins","year":"1998","journal-title":"Nature"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0135","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00002030-199710001-00007","article-title":"Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir","volume":"11","author":"Conant","year":"1997","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/315171","article-title":"Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response","volume":"181","author":"Connick","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0145","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm0597-533","article-title":"HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies","volume":"3","author":"Connors","year":"1997","journal-title":"Nature Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5694\/j.1326-5377.1998.tb123370.x","article-title":"HIV disease progression in Australia in the time of combination antiretroviral therapies","volume":"169","author":"Correll","year":"1998","journal-title":"Med J Aust"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0155","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.7326\/0003-4819-124-12-199606150-00001","volume":"124","author":"D'Aquila","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1086\/515587","article-title":"Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy","volume":"178","author":"Dalod","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(96)05387-1","article-title":"Delta: A randomized double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals","volume":"348","author":"Delta Coordinating Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/infdis\/172.1.79","article-title":"In vitro T cell function, delayed type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus","volume":"172","author":"Dolan","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0175","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0140-6736(05)62136-8","article-title":"Remission of progressive multifocal leukoencephalopathy after antiretroviral therapy","volume":"349","author":"Domingo","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0180","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/25374","article-title":"Changes in thymic function with age and during the treatment of HIV infection","volume":"396","author":"Douek","year":"1998","journal-title":"Nature"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0185","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/bmj.315.7117.1194","article-title":"Impact of new antiretroviral combination therapies in HIV infected people in Switzerland: prospective multicentre study","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0190","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(05)61753-9","article-title":"2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy","volume":"349","author":"Elliot","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00002030-199902040-00005","article-title":"Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients","volume":"13","author":"Foudraine","year":"1999","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0200","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199904293401701","article-title":"Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss Cohort Study","volume":"340","author":"Furrer","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0205","first-page":"1659","article-title":"Acute cytomegalovirus infection in AIDS patients with CD4 counts above 100x10 (6) cells\/l following combination antiretroviral therapy including protease inhibitors","volume":"11","author":"Gilquin","year":"1997","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0210","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/00002030-199814000-00015","article-title":"Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection","volume":"12","author":"Giorgi","year":"1998","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0215","first-page":"1658","article-title":"Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy","volume":"11","author":"Goguel","year":"1997","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nm0298-215","article-title":"Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy","volume":"4","author":"Gorochov","year":"1998","journal-title":"Nature Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0225","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nm0297-212","article-title":"Late escape from an immunodominant cytotoxic T lymphocyte responses associated with progression to AIDS","volume":"3","author":"Goulder","year":"1997","journal-title":"Nature Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0230","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7326\/0003-4819-133-6-200009190-00007","article-title":"Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy","volume":"133","author":"Grabar","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0235","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/aid.1998.14.561","article-title":"Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience","volume":"14","author":"Gray","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0240","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.162.3.1780","article-title":"Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)","volume":"162","author":"Gray","year":"1999","journal-title":"J Immunol"},{"issue":"Suppl. 1","key":"10.1046\/j.0022-202x.2001.00049.x_bb0245","first-page":"S27","article-title":"AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy","volume":"21","author":"Grulich","year":"1999","journal-title":"J Acquir Immun Defic Syndr Hum Retrovirol"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0250","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy","volume":"337","author":"Gulick","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0255","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/318820","article-title":"Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373","volume":"183","author":"Gulick","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0260","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/blood.V90.9.3789","article-title":"Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells","volume":"90","author":"Hakim","year":"1997","journal-title":"Blood"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0265","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJM199610103351501","article-title":"A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team","volume":"335","author":"Hammer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0270","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team","volume":"337","author":"Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0275","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1086\/315381","article-title":"Strong human immunodeficiency virus (HIV) -specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy","volume":"181","author":"Haslett","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0280","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/79549","article-title":"Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the na\u00efve T cell population in HIV-1 infection","volume":"6","author":"Hazenberg","year":"2000","journal-title":"Nature Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0285","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/80481","article-title":"Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques","volume":"6","author":"Hel","year":"2000","journal-title":"Nature Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0290","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/clinids\/24.5.1023","article-title":"Resolution of intractable molluscum contagiosum in a human immunodeficiency virus infected patient after institution of antiretroviral therapy with ritonavir","volume":"24","author":"Hicks","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0295","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/314948","article-title":"A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy","volume":"180","author":"Hirsch","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0300","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.279.6.450","article-title":"Improved survival among HIV-infected individuals following initiation of antiretroviral therapy","volume":"279","author":"Hogg","year":"1998","journal-title":"JAMA"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0305","first-page":"1931","article-title":"Decline in the rate of specific opportunistic infections at San Francisco General Hospital (SFGH): 1994\u201397","volume":"12","author":"Holtzer","year":"1998","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0310","first-page":"1784","article-title":"Complete regression of giant molluscum contagiosum lesions in an HIV-infected patient following combined antiretroviral therapy with saquinavir, zidovudine and lamivudine","volume":"11","author":"Hurni","year":"1997","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0315","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9394(98)00285-2","article-title":"Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"Suppl. 1","key":"10.1046\/j.0022-202x.2001.00049.x_bb0320","first-page":"S34","article-title":"Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study","volume":"21","author":"Jacobson","year":"1999","journal-title":"J Acquir Immun Defic Syndr Hum Retrovirol"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0325","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(96)11431-8","article-title":"Cytomegalovirus retinitis after highly active antiretroviral therapy","volume":"349","author":"Jacobson","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0330","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/319219","article-title":"Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution","volume":"32","author":"Johnson","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"55\u20132","key":"10.1046\/j.0022-202x.2001.00049.x_bb0335","first-page":"1","article-title":"Surveillance for AIDS-defining opportunistic illnesses, 1992\u201397","volume":"48","author":"Jones","year":"1999","journal-title":"MMWR"},{"issue":"Suppl. 1","key":"10.1046\/j.0022-202x.2001.00049.x_bb0340","first-page":"S11","article-title":"Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult\/Adolescent Spectrum of HIV Disease Project Group","volume":"21","author":"Jones","year":"1999","journal-title":"J Acquir Immun Defic Syndr Hum Retrovirol"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0345","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1128\/JVI.73.8.6721-6728.1999","article-title":"Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy","volume":"73","author":"Kalams","year":"1999","journal-title":"J Virol"},{"issue":"Suppl. 1","key":"10.1046\/j.0022-202x.2001.00049.x_bb0350","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0355","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199610103351502","article-title":"The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV infected adults with 200\u2013500 CD4 cells per cubic millimeter","volume":"335","author":"Katzenstein","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0360","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0898-953","article-title":"Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after gancyclovir and highly active antiretroviral therapy in individuals infected with HIV-1","volume":"4","author":"Komanduri","year":"1998","journal-title":"Nature Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0365","doi-asserted-by":"crossref","first-page":"F235","DOI":"10.1097\/00002030-199818000-00001","article-title":"Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy","volume":"12","author":"Kostense","year":"1998","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0370","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9343(98)00321-0","article-title":"Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status?","volume":"105","author":"Kotecha","year":"1998","journal-title":"Am J Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0375","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1172\/JCI114001","article-title":"Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro","volume":"83","author":"Krowka","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0380","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00002030-199902040-00015","article-title":"AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment","volume":"13","author":"Law","year":"1999","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0385","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV cohort study","volume":"282","author":"Ledergerber","year":"1999","journal-title":"JAMA"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0390","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1086\/515591","article-title":"Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS clinical trials group protocol 315","volume":"178","author":"Lederman","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0395","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(97)10291-4","article-title":"Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease","volume":"351","author":"Li","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0400","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jama.282.12.1142","article-title":"Reduced antiretroviral drug susceptibility among patients with primary HIV infection","volume":"282","author":"Little","year":"1999","journal-title":"JAMA"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0405","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-131-2-199907200-00002","article-title":"Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions","volume":"131","author":"Lucas","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0410","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/314628","article-title":"The effect of commencing combination antiretroviral therpay soon after human immunodeficiency virus type 1 intection on viral replication and antiviral immune responses","volume":"179","author":"Markowitz","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0415","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/513823","article-title":"Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy","volume":"177","author":"Marschner","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0420","first-page":"1720","article-title":"Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy","volume":"12","author":"Mayo","year":"1998","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0425","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1172\/JCI8647","article-title":"Factors influencing T-cell turnover in HIV-1-seropositive patients","volume":"105","author":"McCune","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0430","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-130-7-199904060-00005","article-title":"Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study","volume":"130","author":"Miller","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0435","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(98)03201-2","article-title":"Changing patterns of mortality across Europe in patients infected with HIV-1","volume":"352","author":"Mocroft","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0440","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.188.2.233","article-title":"HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy","volume":"188","author":"Morris","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0445","first-page":"261","article-title":"Regression of AIDS related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor","volume":"11","author":"Murphy","year":"1997","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0450","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1086\/314668","article-title":"Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 247 Study Team","volume":"179","author":"Murphy","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0455","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00002030-199904160-00008","article-title":"HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group","volume":"13","author":"Neuman","year":"1999","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0460","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1086\/315013","article-title":"Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults","volume":"180","author":"Notermans","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0465","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/375606a0","article-title":"Antigenic oscillations and shifing immunodominance in HIV-1 infections","volume":"375","author":"Nowak","year":"1995","journal-title":"Nature"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0470","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/JVI.73.1.797-800.1999","article-title":"Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy","volume":"73","author":"Ogg","year":"1999","journal-title":"J Virol"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0475","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1172\/JCI7371","article-title":"HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy","volume":"104","author":"Ortiz","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0480","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00042560-199712150-00002","article-title":"Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents","volume":"16","author":"Pakker","year":"1997","journal-title":"J Acquir Immun Defic Syndr Hum Retrovirol"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0485","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nm0298-208","article-title":"Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation","volume":"4","author":"Pakker","year":"1998","journal-title":"Nature Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0490","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0495","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/517029","article-title":"Regression of invasive AIDS-related Kaposi's sarcoma following antiretroviral therapy","volume":"26","author":"Parra","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0500","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00002030-199902250-00015","article-title":"The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection","volume":"13","author":"Paul","year":"1999","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0505","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00042560-199904150-00017","article-title":"Has the spectrum of AIDS-defining illnesses been changing since the introduction of new treatments and combination of treatments?","volume":"20","author":"Pezzotti","year":"1999","journal-title":"J Acquir Immun Defic Syndr Hum Retrovirol"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0510","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/8400","article-title":"HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression","volume":"5","author":"Pitcher","year":"1999","journal-title":"Nature Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0515","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0140-6736(05)60532-6","article-title":"Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology Study Group of Spanish EARTH-1 Study","volume":"352","author":"Plana","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0520","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/314837","article-title":"functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy","volume":"180","author":"Pontesilli","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0525","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJM199702273360914","article-title":"Remission of progressive multifocal leukoencephalopathy following splenectromy and antiretroviral therapy in a patient with HIV infection","volume":"336","author":"Power","year":"1997","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1046\/j.0022-202x.2001.00049.x_bb0530","first-page":"S31","article-title":"Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS clinical trial group study participants","volume":"21","author":"Rabkin","year":"1999","journal-title":"J Acquir Immun Defic Syndr Hum Retrovirol"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0535","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(97)04352-3","article-title":"Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease","volume":"351","author":"Race","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0540","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/314599","article-title":"Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4T cell reactivity to microbial antigens but not to HIV-1 antigens","volume":"179","author":"Rinaldo","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0545","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/35035103","article-title":"Immune control of HIV-1 after early treatment of acute infection","volume":"407","author":"Rosenberg","year":"2000","journal-title":"Nature"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0550","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-Specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"issue":"Suppl. 2","key":"10.1046\/j.0022-202x.2001.00049.x_bb0555","first-page":"S143","article-title":"HIV type 1-specific helper T cells: a critical host defense","volume":"14","author":"Rosenberg","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0560","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00002030-200003100-00013","article-title":"Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression","volume":"14","author":"Ruiz","year":"2000","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0565","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(98)07204-3","article-title":"Discontinuation of Pneumocystis carinii pneumonia prophylaxis in HIV-1 infected patients treated with highly active antiretroviral therapy","volume":"353","author":"Schneider","year":"1999","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0570","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1089\/aid.1994.10.1703","article-title":"Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long term survivor","volume":"10","author":"Schwartz","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0575","first-page":"S18","article-title":"Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center","volume":"21","author":"Sparano","year":"1999","journal-title":"J Acquir Immun Defic Syndr Hum Retrovirol"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0580","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJM199912163412501","article-title":"Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team","volume":"341","author":"Staszewski","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0585","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0140-6736(05)63173-X","article-title":"Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy","volume":"350","author":"Uthayakumar","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0590","first-page":"538","article-title":"Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy","volume":"12","author":"Valdez","year":"1998","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0595","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002030-200001070-00002","article-title":"Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen","volume":"14","author":"Valdez","year":"2000","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0600","first-page":"116","article-title":"Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy","volume":"12","author":"Vento","year":"1998","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0605","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/JVI.61.6.2017-2023.1987","article-title":"Characteristics of the cell-mediated immune response in human immunodeficiency virus infection","volume":"61","author":"Wahren","year":"1987","journal-title":"J Virol"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0610","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nm0798-852","article-title":"Peripheral expansion of pre-existing T cells is an important means of CD4+ T-cell regeneration in HIV-infected adults","volume":"4","author":"Walker","year":"1998","journal-title":"Nature Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0615","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1097\/00002030-199910010-00007","article-title":"HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia","volume":"13","author":"Wendland","year":"1999","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0620","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(99)03287-0","article-title":"Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group","volume":"353","author":"Weverling","year":"1999","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0625","first-page":"211","article-title":"Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus","volume":"7","author":"Wrin","year":"1994","journal-title":"J Acquir Immun Defic Syndr Hum Retrovirol"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0630","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1073\/pnas.95.3.1154","article-title":"Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection","volume":"95","author":"Zhang","year":"1998","journal-title":"Proc Nat Acad Sci"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0635","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1056\/NEJM199906173402415","article-title":"An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS (letter)","volume":"340","author":"Zietz","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00049.x_bb0640","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJM199606203342516","article-title":"Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir","volume":"334","author":"Zingman","year":"1996","journal-title":"N Engl J Med"}],"container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15529084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15529084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T08:17:20Z","timestamp":1704788240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15529084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":127,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0022202X15529084"],"URL":"https:\/\/doi.org\/10.1046\/j.0022-202x.2001.00049.x","relation":{},"ISSN":["1087-0024"],"issn-type":[{"value":"1087-0024","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}